Fullerenol C ₆₀ (OH) ₁₆ prevents amyloid fibrillization of Aβ ₄₀ – in vitro and in silico approach

This publication has 50 references indexed in Scilit:

• Discovery of Dihydrochalcone as Potential Lead for Alzheimer’s Disease: In Silico and In Vitro Study
  PLOS ONE, 2013
• Fullerenols as a New Therapeutic Approach in Nanomedicine
  BioMed Research International, 2013
• In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells
  Toxicology in Vitro, 2011
• Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction
  Toxicology and Applied Pharmacology, 2010
• Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention
  Experimental Neurology, 2010
• Influence of Preformed Asp23−Lys28 Salt Bridge on the Conformational Fluctuations of Monomers and Dimers of Aβ Peptides with Implications for Rates of Fibril Formation
  The Journal of Physical Chemistry B, 2009
• Comparison of multiple Amber force fields and development of improved protein backbone parameters
  Proteins: Structure, Function, and Bioinformatics, 2006
• Development and testing of a general amber force field
  Journal of Computational Chemistry, 2004
• Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: II. Parameterization and validation
  Journal of Computational Chemistry, 2002
• Comparison of simple potential functions for simulating liquid water
  The Journal of Chemical Physics, 1983